Retaking of the House by Republicans in the mid-term elections in the USA brings uncertainty to the health care overhaul in the US, but it’s not all bad news, explains Datamonitor’s health care analyst Tijana Ignjatovic:
“The Republicans have vowed to repeal the health care reform law passed earlier in 2010, a key Obama policy, should they regain control in the US House of Representatives. However, although they have regained control in the House, with Democrats still in majority in the Senate, and with the White House supporting the reform, a repeal of the health care reform law is unlikely.
She goes on: “Nevertheless, Republicans could stall if not block the implementation of key reform measures by blocking appropriations funding for the least popular elements of the reform. As a result many healthcare lobby groups have already been lobbying for select measures to be removed.
This article is accessible to registered users, to continue reading please register for free. A free trial will give you access to exclusive features, interviews, round-ups and commentary from the sharpest minds in the pharmaceutical and biotechnology space for a week. If you are already a registered user please login. If your trial has come to an end, you can subscribe here.
Login to your accountTry before you buy
7 day trial access
Become a subscriber
Or £77 per month
The Pharma Letter is an extremely useful and valuable Life Sciences service that brings together a daily update on performance people and products. It’s part of the key information for keeping me informed
Chairman, Sanofi Aventis UK
Copyright © The Pharma Letter 2024 | Headless Content Management with Blaze